Compare Quest Diagnostics Inc (DGX) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Quest Diagnostics Inc trades at $204.5 (market cap $22.80B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $53.92. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while First Trust NASDAQ Clean Edge Green Energy Idx Fd pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals.
| DGX | QCLN | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | Sector/Thematic |
52-Week High | $216.02 | $68.47 |
52-Week Low | $166.42 | $34.31 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
QCLN trades at $53.57, down 3.82% with bearish technical signals from moving averages. The clean energy ETF faces mixed sentiment as policy uncertainties from stalled US permits and China restrictions contrast with strong global investment trends. RSI levels suggest potential oversold conditions at 27.51, while ADX indicates strong bearish momentum. Support consolidates around $55 with resistance at $56-57.
The clean energy sector shows long-term growth potential amid energy security concerns and rising demand, but near-term headwinds from US policy uncertainty and supply chain costs create volatility. Investor sentiment remains cautious despite favorable industry tailwinds, requiring careful risk assessment of regulatory developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About First Trust NASDAQ Clean Edge Green Energy Idx Fd
QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →
